#1 Clinical Trials Search in Europe

Microcrystalline Cellulose

Microcrystalline cellulose is a common substance used in clinical trials as a placebo. This article explores various studies where microcrystalline cellulose was utilized to test the efficacy of different drugs and treatments. We’ll examine its use across diverse medical conditions and how it helps researchers evaluate the true effects of experimental medications.

Table of Contents

What is Microcrystalline Cellulose?

Microcrystalline cellulose is not actually a medication, but rather an inactive substance commonly used as a placebo in clinical trials. A placebo is a harmless substance that has no therapeutic effect, used as a control in testing new drugs. It helps researchers determine if the actual medication being studied is effective compared to no treatment at all[1][2].

Uses in Clinical Trials

Microcrystalline cellulose is frequently used in clinical trials as a placebo for various reasons:

  • It’s safe and inert, meaning it doesn’t cause any effects in the body
  • It can be made to look identical to the actual medication being tested
  • It allows researchers to create a “control group” to compare against the group receiving the real medication

In the studies reviewed, microcrystalline cellulose was used as a placebo in trials investigating treatments for conditions such as Long COVID, menstrual pain, knee osteoarthritis, and sleep disorders[1][2][3][4].

Safety and Side Effects

Microcrystalline cellulose is considered very safe for use in clinical trials. As an inactive ingredient, it’s not expected to cause any side effects or have any impact on a person’s health. However, researchers still monitor participants taking the placebo for any unexpected reactions, just as they do for those taking the actual medication being studied[5].

Conditions Studied

While microcrystalline cellulose itself doesn’t treat any conditions, it’s been used as a placebo in studies investigating treatments for various health issues, including:

  • Long COVID: Persistent symptoms after COVID-19 infection[1]
  • Menstrual pain: Discomfort during menstruation[2]
  • Knee osteoarthritis: A degenerative joint disease affecting the knees[3]
  • Sleep disorders: Problems with sleep quality or quantity[4]
  • COVID-19: The disease caused by the SARS-CoV-2 virus[6]

Administration

In clinical trials, microcrystalline cellulose is typically administered in the same way as the actual medication being tested. This helps maintain the “blind” nature of the study, where participants don’t know if they’re receiving the real treatment or the placebo. Some common methods of administration include:

  • Oral capsules: Taken by mouth, often with water[1][2]
  • Tablets: Also taken orally[3]
  • Multiple daily doses: For example, twice or three times per day[6]

The specific dosing schedule and amount of microcrystalline cellulose used will depend on the study design and the medication being tested[4].

Aspect Details
Use of Microcrystalline Cellulose Primarily used as a placebo in various clinical trials
Administration Form Typically in capsule form, matching the appearance and dosing of active drugs
Conditions Studied Long COVID, menstrual pain, COVID-19, Lewy Body Disease, cognitive and physical function in older adults, knee osteoarthritis, sleep quality
Study Designs Double-blind, randomized, placebo-controlled trials
Safety Profile Generally considered safe and inert with no known significant side effects
Importance in Research Allows for accurate assessment of active drug efficacy by providing a neutral comparison
Outcome Measures Varied by study, including pain scales, quality of life assessments, cognitive function tests, and biomarker measurements

FAQ

  • What is microcrystalline cellulose? Microcrystalline cellulose is an inert substance commonly used as a placebo in clinical trials. It's a purified form of cellulose that has no active medicinal properties, making it ideal for comparison with active drugs.
  • Why is microcrystalline cellulose used in clinical trials? Microcrystalline cellulose is used as a placebo because it's safe, has no known side effects, and can be made to look identical to the active drug being tested. This allows researchers to conduct double-blind studies where neither the participants nor the researchers know who is receiving the real drug.
  • In what forms is microcrystalline cellulose administered in trials? In the trials mentioned, microcrystalline cellulose was typically administered in capsule form. It can be made to match the appearance and dosing regimen of the active drug being studied.
  • What types of conditions were studied in trials using microcrystalline cellulose as a placebo? The trials mentioned covered a wide range of conditions, including Long COVID symptoms, menstrual pain, COVID-19, Lewy Body Disease, cognitive and physical function in older adults, knee osteoarthritis, and sleep quality.
  • Are there any risks associated with taking microcrystalline cellulose? Microcrystalline cellulose is generally considered safe and inert. It has no known medicinal effects or significant side effects, which is why it's commonly chosen as a placebo in clinical trials.

Ongoing Clinical Trials on Microcrystalline Cellulose

  • Study on Levothyroxine and Low-Calorie Diet for Weight Loss in Obese Patients with Subclinical Hypothyroidism or High-Normal TSH Levels

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Bosentan for Treating Coronary Artery Spasm in Patients with Ongoing Angina Symptoms

    Recruiting

    1 1 1
    Investigated drugs:
    The Netherlands

  • Study on Maintaining Remission in ANCA-Associated Vasculitis with Prednisone and Rituximab for Patients in Remission from Granulomatosis with Polyangiitis or Microscopic Polyangiitis

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on the Effectiveness and Safety of Prednisone for Patients with Drug-Induced Liver Injury (DILI)

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Preventing Acute Kidney Injury After Heart Surgery Using Empagliflozin in Patients Undergoing Elective Cardiac Surgery

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Methotrexate and Phototherapy for Adults with Progressive Vitiligo

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication

    Not recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on the Effects of Dimethyl Fumarate for Patients with Adrenomyeloneuropathy

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain

Glossary

  • Placebo: A substance or treatment with no active therapeutic effect, used as a control in clinical trials to test the effectiveness of an active drug or treatment.
  • Double-blind study: A research method where neither the participants nor the researchers directly involved know who is receiving the active treatment and who is receiving the placebo.
  • Randomized controlled trial (RCT): A type of scientific experiment that randomly assigns participants into an experimental group or a control group to compare the outcomes.
  • Efficacy: The ability of a drug or treatment to produce a desired effect under ideal circumstances, such as in a controlled clinical trial.
  • Adverse event: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Visual Analogue Scale (VAS): A measurement tool used to assess subjective characteristics or attitudes that cannot be directly measured, often used for pain assessment.
  • Quality of Life (QoL): A measure of an individual's overall well-being, including physical, mental, and social aspects of their life.
  • Biomarker: A measurable indicator of a biological state or condition, often used to assess the presence or progress of a disease or the effects of a treatment.

References

  1. https://clinicaltrials.gov/study/NCT05795816
  2. https://clinicaltrials.gov/study/NCT05810116
  3. https://clinicaltrials.gov/study/NCT01525758
  4. https://clinicaltrials.gov/study/NCT05825209
  5. https://clinicaltrials.gov/study/NCT03468725
  6. https://clinicaltrials.gov/study/NCT04435015